NasdaqGS:GERNBiotechs
Geron (GERN) On Earnings And RYTELO Guidance Looks Undervalued
Geron (GERN) is back in focus after its second quarter 2026 earnings release, fresh RYTELO revenue guidance for 2026 in the US$220 million to US$240 million range, and a new shelf registration filing.
See our latest analysis for Geron.
At a latest share price of US$1.57, Geron has seen a 7 day share price return of 17.16% and a 90 day share price return of 12.95%, while the 1 year total shareholder return of 20.77% contrasts with a 3 year total shareholder return that is down 47.84%. This...